Tyler Sandow
@bayouteazy
Followers
431
Following
634
Media
20
Statuses
240
Interventional radiologist @OchsnerHealth
New Orleans, LA
Joined September 2011
π Intermediate HCC is an obsolete stage and doesn't reflect patient allocation in experienced MDTs. Novel endpoints need to expand options, not eliminate them. ππ» Downstaging to curative intent is the primary goal, always. Local therapy remains the most effective intervention
IKF-035/ABC-HCC phs IIIb: Atezolizumab + Bevacizumab vs TACE in intermediate-stage HCC #ESMO25 #ESMOAmbassadors π TTFS: 14 vs vs 9 mo π§BCLC B is not any more the βdomainβ of local therapies, but intent of treatment is more than ever key for MDT discussion @myesmo @EASLedu
2
6
20
How do you consider acute vs. chronic nature of clot, liver function, history of cirrhosis, and other clinical factors in a case of portal vein thrombosis (PVT)? Learn from expert Dr. Vijay Ramalingam of @BIDMCVIR and his experiences with the Splanchnic Vein Thrombosis
1
14
36
Tough cases call for creative tricks! This week on BackTable, hosts @bahetimd @beckcj and @JMichaelBarraza showcase the highlights from the BackTable tricks and tips competition! Show us some of your best tips! Watch: https://t.co/x0ldsnoue8
@SDhandMD @ChengaziMD @drochohan
0
7
20
RT for a chance to win this Alvin Kamara autographed football! π #Saints | Rules: https://t.co/VLPVphPRtE
152
5K
4K
What matters most in segmental Y-90 dosimetry? Drs. Tyler Sandow & Nima Kokabi break down their approach to rad-segment planning, emphasizing perfused volume over anatomical assumptions. Learn why cone beam CT is their go-to tool, how tumor-to-normal liver ratios influence
1
1
5
With growing demand for image-guided bone marrow biopsy, we created a clear, step-by-step animation to explain the procedure β from prep to sample collection. https://t.co/4LYPRucsyz
@SIRspecialists @Georgetown_IR @thegestgroup @RSNA @cirsesociety #Hematology @SIO_Central
3
2
28
How do experts balance aggressive tumor dosing with liver safety when treating HCC with Y90? Drs. Zach Berman & Tyler Sandow join Dr. Kavi Krishnasamy to break down real HCC cases, from large central tumors, portal vein invasion, and multifocal lesions. Tune in to glean insight
0
3
11
Kamara Birthday Contest π¨ RT for a chance to win an AK autographed #Saints mini helmet π #SaintsContest | Rules: https://t.co/6XFVwYd0re
59
2K
1K
Don't forget about the @_backtable tips and tricks competition! Just submitted 2 this weekend! Going for the "Golden Hoodie"! And, if you're looking for swag, check out the new backtable hats. They even make @kavikrishVIR look good!
π¬ Think your procedural tip could help others in the field? Submit it to the Tricks at the BackTable Competition! π Winning videos will be featured on BackTable+, social media, and win exclusive BackTable gear. First 10 entries receive discount codes for 50% off in the
0
2
10
New: Dosimetry University is now in session! Our first episode dives into treatment planning, from glass vs resin, angio mapping softwares, tumor dosages, to segmentectomy. Tune in to hear from experts Drs. Tyler Sandow, Nima Kokabi, and host @kavikrishVIR . #VI552:
2
4
18
π¬ Think your procedural tip could help others in the field? Submit it to the Tricks at the BackTable Competition! π Winning videos will be featured on BackTable+, social media, and win exclusive BackTable gear. First 10 entries receive discount codes for 50% off in the
2
7
23
Have you heard that we're offering free BackTable+ courses for CME credit? @_backtableONC 's Multi-Disciplinary Tumor Board cours covers 2 hours of content and tracks your learning progress: https://t.co/KjpOyLYLkG
@AstraZeneca @bostonsci
0
2
6
We report our multicenter experience in using either Y90 Radiation Segmentectomy (RS) or Ablative External Beam Radiation Therapy (EBRT) as initial treatment for Solitary Hepatocellular Carcinoma. https://t.co/wxxd6C8nt9 PURPOSE: Prospective data evaluating RS and EBRT has been
9
25
76
New visual abstract from @JVIRmedia article by @bayouteazy & the team at the Oschner Clinic on voxel-based dosimeter for Y90 therapies. Thanks to future #IRad @RylieJu for putting it together!
0
12
39
#Saints contest π¨ RT for a chance to win a Kellen Moore autographed football! Rules: https://t.co/a7SWIYCi4g
77
2K
1K
Today on @_backtableONC : We explore the "grey zone" of treatment goals for #HCC patients with intermediate-stage/BCLC-B disease- https://t.co/w7wkobRd6z Awesome insights from @kiremagarciamd @ZTBerman @SDhandMD @UCSDRadRes @OchsnerHealth #ONC5
0
3
8
Today on @_backtableONC : Here's a primer on the current state of #Immunotherapy for #HCC, courtesy of our medical oncology and IR panel! https://t.co/OhYFE0nPJe
#ONC3
0
4
12
Season 1, Ep. 1- Let's talk about patient flow! Dr. Tyler Sandow hosts a panel discussion about patient care coordination in #HCC diagnosis and treatment, with insights from his colleagues at @OchsnerHealth @jonmizrahi
https://t.co/F6FA8QxENH
#ONC1 #CancerCare @_backtable
backtable.com
Listen to the BackTable Tumor Board Podcast on Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics with Dr. Tyler Sandow, Dr. Jonathan Mizrahi, Dr. Steven Young and...
0
3
7
#Saints Giveaway π¨ RT for a chance to win this @CamJordan94 autographed Mini Helmet! RULES: https://t.co/a7SWIYCi4g
@Nationwide | #WPMOYChallenge
54
1K
808
Y90 RADSEG now #1 bridging treatment in US ahead of TACE, ablation and EBRT @JVIRmedia @allisonkwong @DanSzeMDPhD @SIRspecialists @cirsesociety @ASTSChimera @AASLDtweets @EASLnews @_ILTS_ @AST_info @ASTRO_org @ACRORadOnc @NorthwesternIR @NorthwesternMed
https://t.co/qV328UNiXN
3
39
130